BNIP3 and breast cancer: Ber has been reported as an autophagy inhibitor, with Fu et al. showing that Ber suppresses the accumulation of autophagosomes in breast cancer cells by upregulating BNIP3 and blocking autophagosome–lysosome fusion [38].